Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

CannTrust Holdings

Altria

OrganiGram Holdings Inc.

Bank of America sees 39% upside in this marijuana stock, but a lot would need to go right for that to happen.

The Most Hated Pot Stock Received a Rare Upgrade but Is Still Grossly Overvalued

Canopy Growth

GW Pharmaceuticals

With the industry possibly cooling off, here are the names to remember.

3 Top Marijuana Stocks to Watch in June 2019

Aurora Cannabis

Aphria

HEXO Corp

Tilray Brands

Marijuana investors' favorite stocks are anywhere from 25% to 84% below their all-time highs.

Every Popular Pot Stock Is Now in Bear Market Territory

After the investments from Altria, CRON stock looked like it was headed for significant growth, but Cronos stock has not delivered.
The post Cronos Stock Is Lagging Other Marijuana Names appeared first on InvestorPlace.

Cronos Stock Is Lagging Other Marijuana Names

Investors have had an appetite for cannabis stocks since recreational marijuana was legalized in Canada last year.

Analyst Likes Cronos, But Valuation Suggests 'Downside Potential'

Salesforce

Uber

Options trading was buzzing in Salesforce, Cronos and Uber on Wednesday. Here are the metrics that matter moving forward.

Thursday’s Vital Data: Salesforce, Cronos Group and Uber

Primo Water

Roku

Favorable comments from analysts helped push some stocks higher.

Why Cronos Group, Primo Water, and Roku Jumped Today

Once a seller, Merrill Lynch now thinks this marijuana stock is a buy.

This Just In: Cronos Group Stock Upgraded

CRON stock is flying higher and clearing key resistance in doing so. Now it needs to hold up over these marks to keep the momentum going.

Can Cronos Group Stock Really Run to $20?

Cronos Group Inc. (NASDAQ: CRON) shares popped on Wednesday after Merrill Lynch released a very positive report.

Why Merrill Lynch Has High Hopes for Cronos

Cronos Group shares moved sharply higher after Bank of America Merrill Lynch upgraded the stock to Buy.

Cronos Could Break Out From Downtrend After BoA Upgrade

Cronos Group Inc (NASDAQ: CRON) CEO Mike Gorenstein presented Tuesday at the Consumer Analyst Group of New York lunch.

Analyst: Cronos And Altria Make A Powerful Team

Marijuana stocks: Cronos surged on a double upgrade from Bank of America as the Canadian pot producer plots an "aggressive" move into the U.S. CBD market.

This Marijuana Stock Holds 'Key To Winning The U.S.' Market

Cannabis stocks have been hot in 2019, but Cronos Group Inc (NASDAQ: CRON) shares have lagged the past three months.

Bank Of America Double Upgrades Cronos, Says Bear Thesis 'Increasingly Untenable'

Plunging share prices make it easy to fall into this trap.

The Biggest Mistake Marijuana Stock Investors Are Making Right Now

What is Cronos up to? For investors, there hasn't been much going on lately.

Cronos Stock Is Interesting… but Patience Is Required

The most popular marijuana stock has been outperformed by a variety of cannabis growers.

3 Pot Stocks That Have Left Aurora Cannabis Eating Their Dust Since the Beginning of 2018

These are the pot stocks truly expected to "deliver the green."

Ranking Canada's Top 10 Marijuana Growers

This Canadian marijuana company marches to a different drummer.

Is Cronos Group a Buy?

CRON stock has its critics, but in a very speculative cannabis industry there’s good reasons for investors to own Cronos.

The Case for Buying CRON Stock Is Shaping Up

Innovative Industrial Properties

Marijuana stocks were down Friday as the Food and Drug Administration began its first public hearing on CBD with a cautionary note.

Marijuana Stocks Fall As FDA Chief Sees 'Real Risks' In CBD Products

If you think dilution is no big deal, then you're flat-out wrong.

Share-Based Dilution Has Crushed Pot Stock Returns

Scotts Miracle-Gro

Several CBD manufacturers, researchers, farmers and retailers have urged the regulatory authority to allow the use of cannabis.

FDA to Hold First Public Hearing on Cannabis: 5 Likely Gainers

MediPharm Labs Corp. is a licensed Canadian producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations.

MediPharm Labs: Now Working For Cronos And Very Undervalued

These high-growth pot stocks are trading above their respective consensus price targets.

News for Cronos Group Stock (CRON)